PRP Injections & Treatment Systems in Stamford, CT

CDC PLACES vs. JK: two files, not one brochure

CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Census city-proper population is 135,470. If you are adding prp injections, start with that epidemiology and with National Government Services (NGS) (JK) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 19.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 12.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Connecticut.
• Undiagnosed diabetes is 27.6% of U.S. adults who have the disease (CDC). Wound and joint programs in Connecticut will see patients who were never labeled diabetic on the referral — screening and offloading still belong in the protocol.
• First Coast (Florida) is the only single-state MAC; every other state shares a contractor with neighbors. Connecticut is JK — copy-pasting a Florida LCD packet here is a denial pattern we still see.

Uninsured mix and Medicare CTPs in the same building

JK reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Stamford is 8.6% or not. PLACES is planning data. The LCD is the claim.

Before the first prp injections shipment